NeuroPace appoints Joel Becker CEO and board member, Favet to step down

NeuroPace announced the appointment of Mr. Joel Becker as NeuroPace President & CEO and member of the Board of Directors effective July 10. Michael Favet will be stepping down as CEO and as a member of NeuroPace’s Board of Directors to pursue other opportunities. He has agreed to stay on as a consultant throughout the transition.”Joel brings a distinguished track record of successful commercial leadership and is highly qualified to lead NeuroPace as we move into our next phase of commercial expansion and corporate development,” said Frank Fischer, Chairman of the Board of Directors of NeuroPace. “With over 25 years of diverse experience developing markets, driving growth and leading innovation in medical technologies, from product development to corporate strategy and commercial execution, Joel brings invaluable experience, skills and insight to NeuroPace at a time when we are poised to accelerate adoption of our highly differentiated commercial progress,” added Mr. Fischer. “We wish Mike continued success in his future endeavors and are pleased he has agreed to stay on as consultant through the transition.”